Capabilities
End-to-end cell therapy implementation
Nalmera coordinates every work-stream required to establish and operate a sustainable cell therapy program - from strategy through patient treatment.
Not a point solution. A complete system.
Most cell therapy programs fail not because of the science - but because of the complexity of implementation. Regulatory hurdles, manufacturing gaps, clinical infrastructure deficits, and financial unsustainability derail programs that should succeed.
Nalmera exists to solve this. We are the integration partner that brings every capability under one coordinated engagement - so healthcare systems, governments, and investors can establish programs that actually reach patients.
Our Capabilities
Six integrated workstreams
Each capability is designed to work independently or as part of a fully integrated program engagement.
Program Establishment
From concept to first patient — end-to-end.
Nalmera designs and launches complete CAR-T and advanced cell therapy programs. We coordinate every work-stream - clinical, regulatory, manufacturing, financial, and operational — from initial feasibility through first patient treatment and beyond.
- Feasibility assessment and program design
- Stakeholder alignment and governance structure
- Integrated project management across all workstreams
- Technology partner selection and contracting
- Program launch and first-patient milestone planning
Manufacturing & GMP
Sustainable local production at clinical-grade quality.
We establish GMP-compliant manufacturing capabilities within healthcare systems - enabling local, sustainable production of cell therapy products. Our approach covers facility design, process transfer, quality systems, and scale-up.
- GMP facility design and build-out oversight
- Process transfer from technology partners
- Quality management system (QMS) implementation
- Manufacturing validation and qualification
- Supply chain and cold-chain logistics
Clinical Pathways
Safe, effective treatment protocols built for your context.
We develop the clinical infrastructure required to treat patients safely and effectively - including treatment protocols, patient selection criteria, toxicity management frameworks, and outcome tracking systems.
- Treatment protocol development and adaptation
- Patient selection and referral pathway design
- Toxicity management and safety monitoring frameworks
- Clinical team training and competency assessment
- Outcome data collection and reporting systems
Regulatory Navigation
Country-specific strategy for advanced therapy approval.
Advanced cell therapies face complex, evolving regulatory landscapes. Nalmera develops country-specific regulatory strategies, prepares dossiers, and manages interactions with health authorities to achieve and maintain market authorization.
- Regulatory landscape assessment by country
- Regulatory strategy development and planning
- Dossier preparation and submission management
- Health authority interaction and negotiation
- Post-approval compliance and lifecycle management
Workforce Training
Building the human infrastructure for cell therapy.
A cell therapy program is only as strong as the people running it. We design and deliver comprehensive training programs for every role - clinical, manufacturing, quality, regulatory, and operational - ensuring teams are competent and confident.
- Role-specific training curriculum design
- Clinical team training (physicians, nurses, pharmacists)
- Manufacturing and QC operator training
- Regulatory and quality affairs training
- Ongoing competency assessment and refresher programs
Financial Sustainability
Commercial models that make programs viable long-term.
Cell therapy programs require sophisticated financial architecture to survive beyond initial investment. We develop commercial models, reimbursement strategies, and financial sustainability plans tailored to each healthcare system and market.
- Program cost modeling and financial projections
- Reimbursement strategy and payer engagement
- Health technology assessment (HTA) support
- Revenue cycle and billing infrastructure
- Long-term financial sustainability planning
Why Nalmera
What makes us different
Integration, not advice
We don't hand you a strategy deck and leave. Nalmera embeds alongside your team to execute every work-stream - from regulatory filings to GMP facility commissioning.
Standardized yet adaptable
Our implementation model is built on proven frameworks that adapt to local regulatory, clinical, and commercial environments without sacrificing quality or speed.
Full-stack capability
No other partner covers the full spectrum from program strategy through manufacturing, clinical pathways, regulatory, training, and financial sustainability in a single integrated engagement.
Global network, local execution
We bring a global network of technology partners, regulatory experts, and clinical advisors — deployed with deep local knowledge in each target market.
Ready to build your program?
Whether you need a single capability or a full end-to-end engagement, Nalmera brings the expertise and infrastructure to make it happen.